Background/Aim: The purpose of this study was to evaluate the effect of extracellular vesicles derived from canine M1-polarized macrophages (M1EVs) on canine tumor cells, such as D17 (osteosarcoma cells) and LMeC (melanoma cells). Materials and Methods: Protein expression was determined by western blot analysis. Gene expression was determined by RT-qPCR. In addition, cell apoptosis was analyzed by Annexin V/PI staining. Results: In the case of M1EV, the levels of pro-inflammatory cytokines such as TNFα, IL-6 and IL-1β were increased, and nitrate/nitrite levels were also increased. M1EV induced apoptosis of tumor cells by increasing caspase-3 and caspase-7 activation. In addition, M1EVs decreased expression of CCR4, Foxp3 and CTLA-4 in canine peripheral mononuclear cells cocultured with tumor cells. Conclusion: M1EV could be an effective anti-cancer therapeutic approach in melanoma and osteosarcoma and M1EVs can be used as immunomodulators in the tumor microenvironment for cancer treatment.Cancer is a leading cause of death in companion animals, with mortality rates of approximately 15~30% in dogs (1). Cancers can develop in various dog organs, including the bone (osteosarcoma) and skin/epithelial tissues (melanoma)(2). Osteosarcoma is one of the most malignant tumors affecting the bones in dogs. Appendicular osteosarcoma is the most common form of osteosarcoma in dogs, and accounts for up to 75~85% of all osteosarcoma lesions. This type of cancer is highly aggressive and metastatic, and pulmonary metastasis is common (3). Various modalities have been used to treat osteosarcoma in dogs, including surgical removal, chemotherapy, and radiation therapy, and the median survival time is approximately 103~175 days with surgery and 235~366 days when surgery is combined with chemotherapy (4). Similarly, melanoma is one of the most malignant tumors in dogs, which usually develops in the oral cavity and acral sites (5). Clinical management of melanoma includes surgical resection, radiation therapy, and chemotherapy; however, because of the highly aggressive and metastatic biological behavior of this tumor, controlling the disease using these therapies remains a challenge (6).The tumor microenvironment (TME) is a complex and heterogenous collection of tissues that comprises not only neoplastic cells, but also other diverse immune cells, such as lymphocytes, macrophages, and neutrophils, and this tumorimmune cell cross-talk results in a rich milieu of cytokines and growth factors that play an important role in tumor progression, advancement of inflammation, and angiogenesis (7). Among these immune cells, tumor-associated macrophages (TAMs) represent the major component. These macrophages are mainly classified in two polarization types: 1) the classically activated type 1 macrophage (M1), which produces high levels of proinflammatory cytokines and shows enhanced phagocytosis, and 2) the alternatively activated type 2 macrophage (M2), which facilitates the resolution of inflammation and promotes tissue repair and angiogenesis (...